Eastern Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Eastern Bank's REGN Position: Q2 2026 in Review
Eastern Bank increased its Regeneron Pharmaceuticals (REGN) stake by 30% in Q2 2026, buying an estimated $8.85K and bringing the position to 57 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #669.
Eastern Bank first reported a position in REGN in Q3 2024 and has held it in 8 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Eastern Bank held 57 shares of Regeneron Pharmaceuticals worth $35.5K as of Q2 2026.
- Eastern Bank bought 13 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $8.85K.
- Regeneron Pharmaceuticals made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #669 holding.
- Eastern Bank first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.